Add time:08/08/2019         Source:sciencedirect.com

Erythromycin may stimulate gastrointestinal motor activity via its effect upon motilin receptors. We have studied the ability of the derivative EM-523 (cas 110205-60-2) [de(N-methyl)-N-ethyl-8,9-anhydroerythromycin A 6,9-hemiacetal] to induce contractions in duodenal smooth muscle strips and to displace labeled motilin bound to antral smooth muscle, in man and in rabbit. In both species EM-523 approached the potency of motilin for inducing contractions. Thus pED50 values were 7.84±0.11 and 8.69±0.12 for motilin in, respectively, man and rabbit, against 6.08±0.13 and 8.19±0.10 for EM-523. In rabbit the efficacy of both compounds decreased in parallel aborally, the responses to EM-523 could not be blocked by atropine (10−7 M) or TTX (10−7 M), and both compounds were unable to further enhance the maximum effect to the other compound. In binding studies the order of potency was the same as in the contraction studies. The pIC50 values were: motilin (8.84±0.31, 9.17±0.20) > EM-523 (7.89±0.1, 8.40±0.10). A Schild plot revealed that EM-523 was a competitive inhibitor of motilin receptor binding in man and in rabbit. We conclude that EM-523 is a potent motilin agonist.

We also recommend Trading Suppliers and Manufacturers of EM-523 (cas 110205-60-2). Pls Click Website Link as below: cas 110205-60-2 suppliers